Claim

Discover how a specialized AI model, GPT-4b micro, helped OpenAI and Retro Bio engineer more effective proteins for stem cell therapy and longevity research.

Oracle verdict

This belongs in the register because benchmark and model-release claims set the ceiling for the next wave of deployment stories. The labour-market effect is indirect today, but it becomes direct when these gains are packaged into agents, APIs, and enterprise tools.

Why it matters

Imported from the official OpenAI release stream because it was published on or after the GPT-5 launch date (2025-08-07).

Open source Read thesis appendix

# CopeCheck Capabilities Register

Updated: 2026-06-02T20:47:39Z
Status: live_evidence_active

Question to ask a model: What do these capability claims mean for The Discontinuity Thesis?

Interpretation rule: treat each entry as evidence about capability, deployment, workflow recomposition, labour-market exposure, or institutional framing. Do not treat vendor optimism as neutral; separate the measurable capability claim from the comfort language around it.

## Accelerating life sciences research
Source: https://openai.com/index/accelerating-life-sciences-research-with-retro-biosciences
Publisher: OpenAI
Category: Benchmarks
Sector: Healthcare and life sciences
Capability: Healthcare and life-sciences reasoning
Score: 76/100
Claim: Discover how a specialized AI model, GPT-4b micro, helped OpenAI and Retro Bio engineer more effective proteins for stem cell therapy and longevity research.
Oracle verdict: This belongs in the register because benchmark and model-release claims set the ceiling for the next wave of deployment stories. The labour-market effect is indirect today, but it becomes direct when these gains are packaged into agents, APIs, and enterprise tools.
Thesis relevance: Appendix III, section one: model and benchmark capability evidence